who should avoid glp-1 medications Infographic GLP-1 Safety: Who Should Avoid

Clinical potential of fasting in type 1 diabetes

"There would be risks of malnutrition and the health consequences that go along with that not having enough energy for vital bodily functions is obviously a great concern."

Appendix (Tables 1-2 clickable links)

78% of active Sunnyside Med members achieved a meaningful reduction in their drinking

Efficacy and safety of ITCA 650, a novel drug-device GLP-1 receptor agonist, in type 2 diabetes uncontrolled with oral antidiabetes drugs: the FREEDOM-1 Trial

As a weight loss coach who has been leading people in weight loss for over ten years, plus my experience of maintaining my weight loss for 20+ years, Ive researched this topic extensively